Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 1;147(8):2604-2606.
doi: 10.1093/brain/awae237.

Disentangling genetic risks for development and progression of Alzheimer's disease

Affiliations
Editorial

Disentangling genetic risks for development and progression of Alzheimer's disease

Niklas Mattsson-Carlgren. Brain. .

Abstract

This scientific commentary refers to ‘Towards cascading genetic risk in Alzheimer’s disease’ by Altmann et al. (https://doi.org/10.1093/brain/awae176).

PubMed Disclaimer

Conflict of interest statement

The author reports no competing interests.

Figures

Figure 1
Figure 1
Linking Alzheimer’s disease genetic risk factors to pathobiological disease progression. Altmann and co-workers tested the effects of different genetic risk factors on transitions from A−T− to A+T−, and from A+T− to A+T+. They found that APOE ɛ4 was mainly associated with transition from A−T− to A+T− (the initial development of Alzheimer’s disease), while an Alzheimer’s disease polygenic risk score was only associated with the transition from A+T− to A+T+. A = amyloid; AD = Alzheimer’s disease; T = tau.

Comment on

  • Towards cascading genetic risk in Alzheimer's disease.
    Altmann A, Aksman LM, Oxtoby NP, Young AL; ADNI; Alexander DC, Barkhof F, Shoai M, Hardy J, Schott JM. Altmann A, et al. Brain. 2024 Aug 1;147(8):2680-2690. doi: 10.1093/brain/awae176. Brain. 2024. PMID: 38820112 Free PMC article.

References

    1. Altmann A, Aksman LM, Oxtoby NP, et al. Towards cascading genetic risk in Alzheimer’s disease. Brain. 2024;147:2680-2690. - PMC - PubMed
    1. Ramanan VK, Heckman MG, Przybelski SA, et al. Polygenic scores of Alzheimer’s disease risk genes add only modestly to APOE in explaining variation in amyloid PET burden. J Alzheimers Dis. 2022;88:1615–1625. - PMC - PubMed
    1. Insel PS, Hansson O, Mattsson-Carlgren N. Association between apolipoprotein E ɛ2 vs ɛ4, age, and β-amyloid in adults without cognitive impairment. JAMA Neurol. 2021;78:229–235. - PMC - PubMed
    1. Salvadó G, Grothe MJ, Groot C, et al. Differential associations of APOE-ɛ2 and APOE-ɛ4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia. Eur J Nucl Med Mol Imaging. 2021;48:2212–2224. - PMC - PubMed
    1. Insel PS, Kumar A, Hansson O, Mattsson-Carlgren N. Alzheimer’s disease neuroimaging initiative. Genetic moderation of the association of β-amyloid with cognition and MRI brain structure in Alzheimer disease. Neurology. 2023;101:e20–e29. - PMC - PubMed